| Autor: |
Susana Fichman-Horn, Ella Kaganovsky, Asaf Olshinka, Neelan J. Marianayagam, Shalom Michowiz, Orit Barinfeld, David Hazon, Dror Fixler, A. Hirshberg, Nitza Goldenberg-Cohen |
| Rok vydání: |
2017 |
| Předmět: |
|
| Zdroj: |
Nano Research & Applications. |
| ISSN: |
2471-9838 |
| Popis: |
Background: Glioblastoma multiforme (GBM) is the most common primary malignant brain tumor in adults. Complete resection is impossible. Overexpression of epidermal growth factor receptor (EGFR) by the tumor has been associated with the level of malignancy and possibly with prognosis. Monoclonal antibodies may be used to identify tumor borders. The aim of the present study was to investigate the value of immunostaining with anti-EGFR antibodies conjugated to gold nanoparticles (GNPs) for detecting tumor infiltration into adjacent tissue. Methods: Fresh GBM samples were collected intraoperatively from 14 patients treated at a tertiary medical center in 2014-2015, in accordance with the guidelines of the local and national ethic committees. Demographic, clinical, and outcome data of the patients were recorded. Analysis for EGFR overexpression by polysomy or amplification was determined by calculating the ratio of expression between pairs of the following genes: EGFR, GPER, and RNaseP. Tumor sample with known overexpression of EGFR underwent immunostaining with GNPconjugated anti-EGFR antibodies followed by light-scattering spectroscopy and electron microscopy. The findings were compared with routine hematoxylin and eosin staining. Results: On molecular analysis, EFGR overexpression was identified in 10/14 GBM samples (71%). Amplification was detected in 50% and polysomy in 27%, and one sample showed both. Patients whose samples were characterized by an overexpression of EGFR died within 3-10 months, whereas 2 of the patients with normal EGFR expression were still alive 9 and |
| Databáze: |
OpenAIRE |
| Externí odkaz: |
|
